Literature DB >> 31679998

Extracorporeal Membrane Oxygenation: The New Jack-of-All-Trades?

Jenny Kwak1, Michael B Majewski2, W Scott Jellish2.   

Abstract

The role of extracorporeal membrane oxygenation in the adult patient population still is evolving. Technologic advancements have improved the ability to provide extracorporeal life support. The miniaturization and durability of these systems have made extracorporeal membrane oxygenation more convenient and mobile than ever. Because of these improvements, its use has increased steadily. The indications for use also have diversified. In this review, the authors provide a panoramic view of extracorporeal membrane oxygenation to provide a foundation of knowledge for anesthesiologists.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ECPR; bridge to transplant; cardiogenic shock; extracorporeal membrane oxygenation; mobile ECMO; neurologic complications; postcardiotomy; respiratory failure

Mesh:

Year:  2019        PMID: 31679998     DOI: 10.1053/j.jvca.2019.09.031

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  3 in total

1.  Two cases of intestinal perforation due to mesenteric artery embolism during extracorporeal membrane oxygenation and intra-aortic balloon pumping.

Authors:  Shuai Wang; Mengyuan Diao; Jianrong Wang; Qiao Gu; Ying Zhu; Wei Hu; Bingwei Liu
Journal:  Clin Med (Lond)       Date:  2022-07       Impact factor: 5.410

2.  Commentary: Carbon dioxide embolism during vein harvesting-Directed transesophageal echocardiography for diagnosis and hemodynamic rescue.

Authors:  John G Augoustides
Journal:  JTCVS Tech       Date:  2020-02-23

3.  Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis.

Authors:  Ariane Willems; Peter P Roeleveld; Sonia Labarinas; John W Cyrus; Jennifer A Muszynski; Marianne E Nellis; Oliver Karam
Journal:  Perfusion       Date:  2020-08-29       Impact factor: 1.972

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.